INONasdaq United States
Market cap
$69.022 M
$0.67 -0.86%
Close of 7 Aug 2026
Revenue
$65.3K
#3623 by revenue
Earnings
-$85.0M
Loss-making
Shares outstanding
69,091,956
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Inovio Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.